Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries United Therapeutic (NQ: UTHR ) 316.04 +7.06 (+2.28%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,851,871 Open 311.07 Bid (Size) 302.58 (1) Ask (Size) 329.94 (1) Prev. Close 308.98 Today's Range 308.08 - 317.46 52wk Range 208.62 - 317.46 Shares Outstanding 44,891,523 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Arcellx Stock Earns Relative Strength Rating Upgrade June 21, 2024 One key metric to look for in a stock is an 80-plus Relative Strength Rating. Arcellx stock cleared that benchmark Friday, jumping to 83. Via Investor's Business Daily The 3 Best Medical Device Stocks to Buy in June 2024 June 20, 2024 Medical devices are at the forefront of the digitalization of medicine. making these the three best medical device stocks to buy. Via InvestorPlace Performance YTD +39.01% +39.01% 1 Month +14.32% +14.32% 3 Month +32.85% +32.85% 6 Month +44.36% +44.36% 1 Year +40.32% +40.32% More News Read More Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87 June 20, 2024 Via Investor's Business Daily 10 Health Care Stocks Whale Activity In Today's Session June 19, 2024 Via Benzinga Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans June 14, 2024 Via Investor's Business Daily Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings) June 12, 2024 Via Benzinga Expert Ratings For United Therapeutics May 21, 2024 Via Benzinga The Latest Analyst Ratings For United Therapeutics May 02, 2024 Via Benzinga Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade June 12, 2024 Via Investor's Business Daily Krystal Biotech Stock Sees RS Rating Jump To 91 June 11, 2024 Via Investor's Business Daily 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga Halozyme Therapeutics Scores RS Rating Jump To 91 June 07, 2024 Via Investor's Business Daily For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals. June 05, 2024 Via Chartmill United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From United Therapeutics Corporation Via Business Wire The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 June 04, 2024 Via InvestorPlace Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics June 03, 2024 Via Investor's Business Daily Topics Intellectual Property Exposures Intellectual Property 7 Biotech Stocks That Could Breathe New Life Into Your Portfolio May 20, 2024 Via InvestorPlace Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating May 16, 2024 Via Investor's Business Daily NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. May 15, 2024 Via Chartmill Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating May 14, 2024 Via Investor's Business Daily 3 Biotech Stocks to Double Your Money in the Next 24 Months May 06, 2024 Via InvestorPlace Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity May 01, 2024 Via Benzinga UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 Via InvestorPlace Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday May 01, 2024 Via Benzinga United Therapeutics Corporation Reports First Quarter 2024 Financial Results May 01, 2024 From United Therapeutics Corporation Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.